The story of man's victory over smallpox is one of determination, scientific endeavour and vaccination on a global scale. Colette Flight delves into the dark history of the 'Speckled Monster'.
By Colette Flight
Last updated 2011-02-17
The story of man's victory over smallpox is one of determination, scientific endeavour and vaccination on a global scale. Colette Flight delves into the dark history of the 'Speckled Monster'.
An estimated 300 million people died from smallpox in the 20th century alone. This virulent disease, which kills a third of those it infects, is known to have co-existed with human beings for thousands of years. As the world's population grew, and travel increased, so the virus that Edward Jenner called the "speckled monster" grasped every opportunity to colonise the world.
The earliest physical evidence of smallpox is the pustular rash on the mummified body of Pharaoh Ramesses V of Egypt, who died in 1157 BC. Traders carried the disease from Egypt to India during the 1st millennium BC. From there it swept into China in the 1st century AD and reached Japan in the 6th century. Returning crusaders provided a way for smallpox to spread through Europe in the 11th and 12th centuries.
Smallpox was particularly successful in virgin populations. The Spanish inadvertently owe much of their success in conquering the Aztecs and Incas in Mexico in the 16th century to smallpox. Unlike the Spanish, the native Indians had no immunity to the disease, having never encountered it before. It wiped out huge numbers of them. A century later the North American Indians suffered a similar devastation. In the 18th century smallpox decimated the aborigines when it reached Australia, the last corner of the world to have escaped its ravages.
he Spanish inadvertently owe much of their success in conquering the Aztecs and Incas in Mexico in the 16th century to smallpox.
People struggled to find ways to battle with smallpox. Variolation was a process developed in the 10th century in China and India. It involves taking pus from the pocks of someone suffering from smallpox and inoculating healthy people with it. Usually a mild case of smallpox developed, giving lifelong immunity afterwards. There was a risk of death from this, but in a world where smallpox was rife the odds made it worthwhile; about 0.5-2 percent of people died after variolation, compared with 20-30 per cent after natural smallpox. A major disadvantage of the practice was that variolated people could pass on severe smallpox to others.
Lady Mary Wortley Montagu (1689-1762) is credited with introducing variolation to Britain in 1721. Severely pockmarked herself after surviving the illness, she learnt about variolation in Constantinople, where her husband was the British Ambassador. She had her children inoculated and persuaded the Princess of Wales to do the same.
The real breakthrough in fighting the virus came in 1796, when Edward Jenner carried out his famous experiment. He inserted pus extracted from a cowpox pustule on the hand of a milkmaid, into an incision on the arm of an eight-year-old boy, James Phipps. Jenner was testing his theory, drawn from the folklore of the countryside, that milkmaids who suffered the mild disease of cowpox never contracted smallpox. Jenner proved conclusively that contracting cowpox provided immunity against smallpox as well. He was quick to realise the enormous potential of vaccination. In 1801 he wrote 'It now becomes too manifest to admit of controversy, that the annihilation of the Small Pox, the most dreadful scourge of the human species, must be the final result of this practice.'
It was to be well over a hundred years before Jenner's vision finally began to be realised. In 1959 the World Health Assembly passed a resolution to undertake the global eradication of smallpox. The goal of eradication made sense to the developed countries in Europe and North America. Although vaccination had largely wiped out the disease from these areas, they all continued to suffer outbreaks of smallpox caused by imports from developing countries where the disease was endemic.
There were a number of outbreaks that demonstrated how a few smallpox cases could spark mass panic and large-scale disruption. In 1947 a Mexican businessman, unaware he was incubating smallpox, travelled by bus to New York. Worried that a smallpox epidemic would spiral out of control in the densely populated city, the health authorities decided to act pre-emptively and mass vaccinate New Yorkers. Over six million people were vaccinated within a month at hundreds of vaccination stations in hospitals, firehouses, and police stations. In all, 12 people caught smallpox and two of them, including the Mexican, died. Ironically six people also died from adverse reactions to the vaccine.
In Wales in 1962 a traveller from Pakistan seeded a smallpox outbreak in the Rhondda. Twenty-five people contracted smallpox, and six of them died, including a nine-month-old baby. As the epidemic grew, so did the public clamour for vaccination, and 900,000 people were eventually vaccinated in South Wales.
One of the last major European outbreaks was in Yugoslavia in 1972. Smallpox was not diagnosed until the epidemic was well under way, and Tito's Communist government took draconian measures to bring the outbreak under control. Despite this, there were still 175 cases and 35 deaths. A Muslim pilgrim had returned from Mecca to his village in Kosovo via Iraq, where there were cases of smallpox, and spread the disease to friends and relatives. A man called Ljatif Muzza in nearby Djakovica also became infected.
Muzza fell ill and because of the seriousness of his condition was treated in a series of hospitals, ending up in Belgrade on 10th March. Nurse Dusanka Stupar was on duty that night with her colleague Dusica Spasic. Muzza had been misdiagnosed as suffering from a bad reaction to penicillin. In fact he had contracted the most virulent and highly contagious form of smallpox - hemorrhagic - in which the patient bleeds to death before developing pustules. He died later that night.
It was a place of waiting for life or death... for the next 15 days we will live together and wait to see whose turn it is next...
The morning after Muzza's death Dusanka came down with measles and was forced to take a few weeks off work. During her absence the first smallpox cases appeared in Belgrade. Incredibly Muzza infected 38 people, eight of whom died. The first Dusanka knew about the epidemic was when health officials turned up at her home on 23rd March to take her in to quarantine. A few days later she discovered that her friend, Dusica, had already died of the disease. Enforced mass quarantine was instigated to stop the virus in its tracks. Dusanka recorded her experience of it in a diary. She was kept in a hotel guarded by armed police. It was 'a place of waiting for life or death... from today for the next 15 days we will live together and wait to see whose turn it is next.' Dusanka smuggled the diary out in her underwear; it was forbidden to take possessions out of quarantine for fear of infection.
Dr Suvakovic, who had seen smallpox in India, was part of a special team sent to Kosovo from Belgrade to deal with the epidemic. He was shocked when he reached the smallpox hospital in Dakovica. Having never encountered smallpox before, the terrified doctors had abandoned their patients. Dr Birtasevic, an army medical doctor, remembers the strict measures taken to prevent the epidemic spreading outside Kosovo.
The province was isolated, and no one allowed in or out without having been vaccinated. Public events, meetings and weddings were forbidden. He and his team vaccinated throughout the region. 'The working day was from when the sun came up to when it went down. It was very exhausting; there were no breaks, no Sundays or public holidays.' In the end almost the entire Yugoslavian population of 18 million people was vaccinated.
...almost the entire Yugoslavian population of 18 million people was vaccinated.
It was fear of these kinds of epidemics that encouraged developed countries to fund the smallpox eradication campaign. Seven years after it had been proposed the campaign began in earnest in 1966 with the appointment of DA Henderson. Although mass vaccination calmed fears, it was not always the most medically efficient way to combat the disease. Henderson and his team developed a strategy of containment and surveillance. Every time there was an outbreak, a WHO team would arrive, vaccinate and isolate those who were ill and trace and vaccinate all their contacts. Effectively they ring-fenced the disease until it had no way of moving on to its next victim. The eradication teams also actively hunted down the disease, travelling with a 'recognition card' showing a baby with smallpox, to explain to people what the illness looked like. Rewards were offered to encourage reporting of cases.
The last natural case of smallpox was in Somalia in October 1977. Ali Maow Maalin, a 23-year-old hospital cook in Merca, had never been successfully vaccinated. After his diagnosis, an intensive tracing and vaccination campaign led to 54,777 people being vaccinated in the next two weeks. The disease was cornered, with no vulnerable hosts nearby to spread to. DA Henderson and his team rejoiced at the thought there would never be another case of this horrendous disease again. There were no official announcements, however, until a two-year period of intense surveillance was completed, making sure the disease was finally gone.
It was just as well. Smallpox made one last attempt to stage a comeback. In September 1978 Janet Parker, a medical photographer at the University of Birmingham, was accidentally infected with smallpox and later died. Her illness was initially diagnosed as a drug rash, but soon afterwards pustules appeared on her body. Mrs Parker's mother also developed smallpox, but survived. The ensuing investigation never established exactly how the smallpox virus had escaped from the university's laboratory.
This accident was a sharp reminder that humans remained vulnerable to the disease, especially as routine vaccination had ended in many countries in the 1970s. Following their jubilant announcement in 1980 that smallpox had finally been eradicated from the world, the World Health Organization lobbied for the numbers of laboratories holding samples of the virus to be reduced. In 1984 it was agreed that smallpox be kept in only two WHO approved laboratories, in Russia and America.
Twenty-two years after eradication, the world has little herd immunity and we have never been so vulnerable to smallpox.
Today these stocks still exist at the State Research Center of Virology and Biotechnology (Vector) in Koltsovo, Russia, and at the Centers for Disease Control and Prevention (CDC), Atlanta, in the United States. The World Health Assembly has passed resolutions to destroy the stocks, but each time the date of destruction has been postponed to allow ongoing research. In May 1999 it was decided to postpone destruction until 2002. The Americans announced in November 2001 that they have now decided not to destroy their stocks.
In 2002, twenty-two years after eradication, the people of the world have little herd immunity to smallpox, and we have never been so vulnerable to it. In the late 1990s the public discovered that we still have reason to fear this virus. While the rest of the planet had celebrated the elimination of this horrendous disease, the Russians had embarked on an ambitious smallpox programme of their own; to turn it into an effective weapon.
Smallpox 1961-62 - Reports on Public Health and Medical Subjects, no 109 (Ministry of Health, HMSO,1963)
Smallpox and its Eradication by F Fenner, DA Henderson, I Arita, Z Jezek, ID Ladnyi (World Health Organization, 1988)
The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradication (World Health Organization, Geneva, 1980)
Collette Flight was an Assistant Producer on Smallpox 2002 - Silent Weapon, a WalltoWall production for BBC Current Affairs.
BBC © 2014 The BBC is not responsible for the content of external sites. Read more.
This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.